Immediate Impact
23 standout
Citing Papers
Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
2025 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Masanari Hamaguchi being referenced
CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
2022
Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Masanari Hamaguchi | 78 | 75 | 28 | 19 | 132 | |
| Luis Acaba-Berrocal | 47 | 60 | 32 | 15 | 192 | |
| Anne Sibille | 132 | 79 | 50 | 21 | 194 | |
| Mikako Ishijima | 121 | 106 | 17 | 15 | 175 | |
| Rebecca Hoyd | 108 | 41 | 46 | 27 | 170 | |
| Huiqiang Huang | 70 | 48 | 34 | 14 | 185 | |
| Masayuki Shirasawa | 157 | 100 | 26 | 25 | 200 | |
| Omar Abdihamid | 71 | 77 | 73 | 26 | 180 | |
| Marcelo Luiz Balancin | 45 | 48 | 30 | 20 | 130 | |
| Marc Cucurull | 75 | 35 | 28 | 17 | 102 | |
| Kinnosuke Matsumoto | 52 | 60 | 10 | 20 | 103 |
All Works
Loading papers...